Addressing the crisis in antibiotic development
WHO experts to travel to China
Update from WHO and Pew Charitable Trusts: urgent action needed to accelerate antibiotic development
WHO launches iSupport Lite
WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls
Complementarity of governance structures for antimicrobial resistance: The Independent Panel for Evidence, The Global Leaders Group and the Partnership Platform
WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19
Introductory meeting of WHO’s Strategic and Technical Advisory Group for Tuberculosis
WHO announced as a Global Leader of the Generation Equality Action Coalition on ending gender-based violence
WHO speaks at the European Parliament on the COVID-19 response
